An internationally recognized expert in hematology, transfusion and transplantation, and cellular/gene therapies, Dr. Hillyer brings a unique combination of vision, executional experience, and proven success as a business executive, scientist, board member, and global leader. During his tenure, Hillyer has transformed NYBCe into a $600M+/yr multi-faceted life sciences organization with global reach and worldwide recognition for its high humanitarian impact, R&D, and commercialization strategies. Today, NYBCe serves 75M+ people and 600+ hospitals, research organizations, academic institutions, and biomedical companies in nearly 45 countries. In 2021, Hillyer founded NYBC Ventures, a $50M earl